Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accent MicrocellNSE:ACCENTMIC +0.71%19 Days Payable is 41.90 as of Mar. 2025, which is 42% below its 10-year median of 71.67. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 926 Drug Manufacturers companies, Accent Microcell ranks worse than 81.97% on this metric.
The historical rank and industry rank for Accent Microcell's Days Payable or its related term are showing as below:
NSE:ACCENTMIC'
s Days Payable Range Over the Past 10 Years
Min: 41.9 Med: 71.67 Max: 97.08
Current: 41.9
During the past 5 years, Accent Microcell's highest Days Payable was 97.08. The lowest was 41.90. And the median was 71.67.
NSE:ACCENTMIC's Days Payable is ranked worse than 81.97% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.455
vs NSE:ACCENTMIC: 41.90
Accent Microcell's Days Payable
declined
from Mar. 2023 (97.08) to Mar. 2025 (41.90).
It may suggest that Accent Microcellaccelerated paying its suppliers.
Accent Microcell Days Payable Related Terms
Accent Microcell Days Payable Historical Data
* Premium members only.
The historical data trend for Accent Microcell's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell Days Payable Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Days Payable
71.67
76.36
97.08
66.26
41.90
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Days Payable
71.67
76.36
97.08
66.26
41.90
NSE:ACCENTMIC vs ZTS, UTHR: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Days Payable distribution charts can be found below:
* The bar in red indicates where Accent Microcell's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Accent Microcell's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell (NSE:ACCENTMIC) has a Days Payable of 41.90 as of Mar. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Accent Microcell and its competitors. This is 42% below median its historical median of 71.67. Over the past decade, Accent Microcell's Days Payable has ranged from 41.90 to 97.08. According to the industry distribution chart, Accent Microcell ranks #759 out of 926 companies in the Drug Manufacturers industry, placing it in the top 82%.
Is Accent Microcell's Days Payable too high?
Accent Microcell's current Days Payable of 41.90 is 42% below median its 10-year median of 71.67. Over the past 10 years, this metric has ranged from a low of 41.90 to a high of 97.08. The Drug Manufacturers industry median Days Payable is 90.46. Accent Microcell's value of 41.90 is 53.7% below this industry median. Based on the distribution chart, Accent Microcell ranks #759 out of 926 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #759 out of 926 companies for Days Payable. This places Accent Microcell in the lower half of its industry. The industry median Days Payable is 90.46. Accent Microcell's value of 41.90 is 53.7% below this benchmark. Historically, Accent Microcell's own Days Payable has ranged from 41.90 to 97.08 over the past decade. While the company's 10-year median is 71.67 vs. the industry median of 90.46, Accent Microcell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.46, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current Days Payable of 41.90 is 53.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current Days Payable is 41.90, which is 42% below median its own 10-year median of 71.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current Days Payable of 41.90. The current Days Payable is 41.90, which is 42% below median its 10-year median of 71.67 and 53.7% below the Drug Manufacturers industry median of 90.46. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current Days Payable is 41.90 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score
Get the complete analysis for NSE:ACCENTMIC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 
